RJ-34

• Description :

  RJ-34, an aristolactam analogue, exhibits potent antitumor activities against a broad array of cancer cell lines with GI50 values in the subnanomolar range (GI50 [1].

• UNSPSC :

  12352005

• Target :

  Drug Derivative

• Type :

  Reference compound

• Related Pathways :

  Others

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/rj-34.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C1N(CCN(C)C)C2=C3C1=CC(OC)=C(OC)C3=C(C=C4)C(C5=C4OCO5)=C2

• Molecular Formula :

  C22H22N2O5

• Molecular Weight :

  394.42

• References & Citations :

  [1]Nafie MS, et al. Exploration of novel VEGFR2 tyrosine kinase inhibitors via design and synthesis of new alkylated indolyl-triazole Schiff bases for targeting breast cancer. Bioorg Chem. 2022;122:105708.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [1170694-29-7]